| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3293807 | Gastroenterology | 2012 | 11 Pages |
Abstract
Immunosuppression increases the risk of melanoma and NMSC among patients with IBD. The risk of melanoma is increased by use of biologics, and the risk of NMSC is increased by use of thiopurines. Patients with IBD should be counseled and monitored for skin cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Millie D. Long, Christopher F. Martin, Clare A. Pipkin, Hans H. Herfarth, Robert S. Sandler, Michael D. Kappelman,